IMR Press / CEOG / Volume 39 / Issue 4 / pii/1630475818217-1626761242

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Oocytes from women of advanced reproductive age do not appear to have an increased risk of zona pellucida hardening
Show Less
1 Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology Division of Reproductive Endocrinology & Infertility, Camden, NJ (USA)
Clin. Exp. Obstet. Gynecol. 2012, 39(4), 440–441;
Published: 10 December 2012
Abstract

Purpose: To test the hypothesis that very advanced reproductive age leads to an increased risk of zona pellucida hardening by comparing fertilization rates and rates of failed fertilization with conventional oocyte insemination vs intracytoplasmic sperm injection (ICSI). Methods: Women aged ≥ 45 were given the option of ICSI vs conventional oocyte insemination in circumstances where there was no male factor present. They were advised of the theoretical benefit of ICSI overcoming zona hardening but also advised that ICSI might lower pregnancy rates and is more costly. Results: There were 364 cycles evaluated and 74% chose ICSI. The failed fertilization rates were similar – 28.4% (66/232) for ICSI vs 26.5% (35/132) for conventional insemination. The fertilization rates were similar 56.0% with ICSI vs 50.9% with conventional oocyte insemination. Conclusion: Based on similar fertilization and failed fertilization rates in women aged ≥ 45 undergoing IVF-ET, zona hardening does not appear to be a consequence of reproductive aging.
Keywords
Reproductive aging
Zona pellucida hardening
Intracytoplasmic sperm injection
In vitro fertilization-embryo transfer
Pregnancy rates
Share
Back to top